Cemiplimab for advanced cutaneous squamous cell carcinoma: survival gains at acceptable cost
Source: PharmacoEconomics and Outcomes News - Category: Drugs & Pharmacology Source Type: news
More News: Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Skin Cancer | Squamous Cell Carcinoma